Simvastatin Reduces Atherosclerosis in Mice
Author Information
Author(s): Song Guohua, Liu Jia, Zhao Zhenmei, Yu Yang, Tian Hua, Yao Shutong, Li Guoli, Qin Shucun
Primary Institution: Institute of Atherosclerosis, Taishan Medical University
Hypothesis
Simvastatin might promote the expression of several factors involved in reverse cholesterol transport.
Conclusion
Simvastatin effectively reduces atherosclerotic lesion formation in apoE-/- mice fed a high-fat diet.
Supporting Evidence
- Simvastatin reduced atherosclerotic lesion formation by 35% in the aortic root and 47% in the aortic arch.
- Plasma HDL-C and apoA-I levels were significantly increased by simvastatin treatment.
- Simvastatin treatment elevated the expression of hepatic ABCB4 and ABCG5.
Takeaway
Simvastatin helps lower bad cholesterol and prevents heart disease by helping the body get rid of cholesterol.
Methodology
21 male apoE-/- mice were divided into two groups, one treated with simvastatin and the other with a vehicle, and fed a high-fat diet for 6 weeks.
Limitations
The study was conducted on a specific mouse model, which may not fully represent human responses.
Participant Demographics
Male apoE-/- mice, 5 weeks old.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website